Weight LossRankings
CompareSemaglutideTirzepatideSavings CalculatorWeight Loss Calculator

Browse by City

Compare GLP-1 telehealth providers and local clinic options in the 20 largest US cities. Pricing, availability, and insurance vary by location.

New York, NY
Pop. 8,336,817 · Obesity 27.3%
Los Angeles, CA
Pop. 3,979,576 · Obesity 26.2%
Chicago, IL
Pop. 2,693,976 · Obesity 31.4%
Houston, TX
Pop. 2,304,580 · Obesity 34.1%
Phoenix, AZ
Pop. 1,680,992 · Obesity 30.9%
Philadelphia, PA
Pop. 1,584,064 · Obesity 32.8%
San Antonio, TX
Pop. 1,547,253 · Obesity 35.2%
San Diego, CA
Pop. 1,423,851 · Obesity 25.4%
Dallas, TX
Pop. 1,343,573 · Obesity 33.0%
Austin, TX
Pop. 978,908 · Obesity 28.6%
Fort Worth, TX
Pop. 918,915 · Obesity 33.2%
Jacksonville, FL
Pop. 911,507 · Obesity 29.7%
Columbus, OH
Pop. 898,553 · Obesity 34.4%
Charlotte, NC
Pop. 885,708 · Obesity 32.1%
Indianapolis, IN
Pop. 876,384 · Obesity 36.1%
San Francisco, CA
Pop. 873,965 · Obesity 22.4%
Seattle, WA
Pop. 753,675 · Obesity 27.7%
Denver, CO
Pop. 715,522 · Obesity 24.2%
Washington, DC
Pop. 712,816 · Obesity 24.7%
Boston, MA
Pop. 675,647 · Obesity 25.0%
Sources & methodology — as of May 2026⌄
  1. 1.CDC BRFSS — Adult Obesity Prevalence Maps by State (Behavioral Risk Factor Surveillance System)— Centers for Disease Control and Prevention.
Weight LossRankings

Independent, unbiased rankings of weight loss programs and GLP-1 providers.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Compare

  • All Providers
  • Provider Reviews
  • Alternatives
  • Best Semaglutide
  • Best Tirzepatide
  • Best Orforglipron
  • Best Supplements
  • Best Programs

Browse

  • By State
  • By City
  • By Drug
  • By Insurance
  • By Pharmacy
  • FDA Warning Letters

Tools

  • Live Price Tracker
  • BMI Calculator
  • GLP-1 Unit Converter
  • Drug Interaction Checker
  • Insurance Employer Checker
  • All Tools

Learn

  • Research
  • Glossary
  • Drug Guides
  • Methodology
  • Editorial Policy
  • Corrections
  • Sources
  • FAQ

Company

  • About
  • Editorial Team
  • Contact
  • Careers
  • Press
  • Advertise
  • Medical Disclaimer
  • Nature of Reviews
  • Disclosure
  • Code of Conduct
  • Privacy
  • Terms
  • Trademarks

The information on this website is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Wegovy®, Ozempic®, Rybelsus®, and Saxenda® are registered trademarks of Novo Nordisk A/S. Mounjaro®, Zepbound®, and Foundayo® are registered trademarks of Eli Lilly and Company. All other product names referenced are trademarks of their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer.

© 2026 WeightLossRankings.org. All rights reserved.